[Tuberculosis in the 21st centruy].
Casal
M
M
D017088:AIDS-Related Opportunistic Infections / Q000453:epidemiology; D000995:Antitubercular Agents / Q000494:pharmacology / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D004352:Drug Resistance, Microbial; D005544:Forecasting; D006801:Humans; D017053:Infection Control / Q000639:trends; D008826:Microbial Sensitivity Tests / Q000191:economics; D009169:Mycobacterium tuberculosis / Q000187:drug effects / Q000235:genetics; D014376:Tuberculosis / Q000188:drug therapy / Q000191:economics / Q000453:epidemiology / Q000517:prevention & control; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy / Q000191:economics / Q000453:epidemiology / Q000517:prevention & control
D000995:Antitubercular Agents